Metraipolis › archive › dc_2fc337664945

Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic… — Europe PMC PMID:42793688

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42793688
DOI
10.3390/diagnostics16182902
License (as archived)
solo-consultazione
Archived
2026-10-15T21:59:40.643Z
SHA-256 of the archived text
9f55e67ae93ca8c9d037259458ccd8286a5208182481c79bdaab05de59d5b67d
Stable URL of this page
https://metraipolis.com/documento/dc_2fc337664945

How to cite

Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic… — Europe PMC PMID:42793688 — Europe PMC (en), https://europepmc.org/article/MED/42793688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2fc337664945 (Metraipolis archive dc_2fc337664945, sha256 9f55e67ae93ca8c9d037259458ccd8286a5208182481c79bdaab05de59d5b67d)
BibTeX
@misc{dc2fc337664945,
  title = {Molecular Classification of Endometrial Cancer in the Era of Precision Oncology: Prognostic Significance, Emerging Biomarkers, and Personalized Therapeutic… — Europe PMC PMID:42793688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42793688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2fc337664945; sha256 9f55e67ae93ca8c9d037259458ccd8286a5208182481c79bdaab05de59d5b67d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42793688. Agents can read the archived copy with the MCP tool read_document.